hnRNP F directs formation of an exon 4 minus variant of tumor-associated NADH oxidase (ENOX2). (Q39533462)

12 September 2017

title

hnRNP F directs formation of an exon 4 minus variant of tumor-associated NADH oxidase (ENOX2). (English)

1 reference

12 September 2017

4

D James Morré

1 reference

12 September 2017

Xiaoyu Tang

1

1 reference

12 September 2017

Vanessa D Kane

series ordinal

2

1 reference

12 September 2017

Dorothy M Morré

series ordinal

3

1 reference

12 September 2017

publication date

28 May 2011

1 reference

Molecular and Cellular Biochemistry

12 September 2017

published in

1 reference

12 September 2017

volume

357

1 reference

12 September 2017

issue

1-2

1 reference

12 September 2017

page(s)

55-63

1 reference

A multifunctional hydroquinone oxidase of the external cell surface and sera

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

Cell Surface NADH Oxidases (ECTO-NOX Proteins) with Roles in Cancer, Cellular Time-keeping, Growth, Aging and Neurodegenerative Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

Cancer isoform of a tumor-associated cell surface NADH oxidase (tNOX) has properties of a prion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

Alternative splicing as the basis for specific localization of tNOX, a unique hydroquinone (NADH) oxidase, to the cancer cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

Transgenic mouse line overexpressing the cancer-specific tNOX protein has an enhanced growth and acquired drug-response phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

Early developmental expression of a normally tumor-associated and drug-inhibited cell surface-located NADH oxidase (ENOX2) in non-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

Monoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

Human neuronal cell protein responses to Nipah virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

Systematic identification and analysis of exonic splicing silencers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

Determination of the RNA binding specificity of the heterogeneous nuclear ribonucleoprotein (hnRNP) H/H'/F/2H9 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

The hnRNP F protein: unique primary structure, nucleic acid-binding properties, and subcellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

Heterogeneous nuclear ribonucleoproteins H, H', and F are members of a ubiquitously expressed subfamily of related but distinct proteins encoded by genes mapping to different chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

Alternative splicing regulation during C. elegans development: splicing factors as regulated targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

A G-tract element in apoptotic agents-induced alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

Heterogeneous nuclear ribonucleoproteins F and H/H' show differential expression in normal and selected cancer tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

An apparent pseudo-exon acts both as an alternative exon that leads to nonsense-mediated decay and as a zero-length exon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

Identification of novel splice variants of the human CD44 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

The gene encoding the splicing factor SF2/ASF is a proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0875-5

tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21625959

12 December 2020

inferred from PubMed ID database lookup

A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea N-4-(methylphenylsulfonyl)-N'-(4-chlorophenyl)urea (LY181984) specific to sera from cancer patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21625959

12 December 2020

inferred from PubMed ID database lookup

NADH oxidase activity from sera altered by capsaicin is widely distributed among cancer patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21625959

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11010-011-0875-5

1 reference

release_fvgnrvrdtrbcxacbr3eiv6hplm

12 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fvgnrvrdtrbcxacbr3eiv6hplm

24 November 2022

mapped directly with Wikidata item

1 reference